John Kelly: Luck, creativity key for station Florida Today The biggest threat to the International Space Station is that the shuttles are being retired. Engineers designed the space station on the idea that shuttle orbiters would visit every so often. / NASA file NASA's got a plan for keeping the International ... |
Sunday, May 15, 2011
John Kelly: Luck, creativity key for station - Florida Today
iwegasely.wordpress.com
Friday, May 13, 2011
Bert Trautmann: 'Stoke have better team spirit. I'd make them favourites' - The Independent
dusinenezoqoc.blogspot.com
The Guardian | Bert Trautmann: 'Stoke have better team spirit. I'd make them favourites' The Independent Unless something truly extraordinary occurs in tomorrow's FA Cup final, 87-year-old Bert Trautmann, the goalkeeper who in the 1956 final successfully protected Manchester City's 3-1 lead over Birmingham City despite an injury that turned out to be a ... Seve B » |
Tuesday, May 10, 2011
UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients
http://www.urbanmoms.ca/mt/mt-cp.cgi?__mode=view&blog_id=52&id=31305
The phase III study is assessingh the safety and efficacyof StemEx(R), an investigational productt derived from stem cells, as an alternativ treatment to bone marrow transplants for hematologicaol malignancies, including leukemia and lymphoma. StemEc is a graft of expanded stem/progenitor cells taken from a singlse unit of umbilical cord blood and then transplanted in combinationwith non-expanded cells from the same "I am extremely pleased UPCI has the opportunitu to be a part of this study," said Mounzer Agha, M.D.
, clinical director of UPCI's Hematopoieticc Stem Cell Transplant "Using umbilical cord blood stem cells instead of a traditionaol bone marrow transplant opens tremendous treatment possibilities for patients with diseasez like leukemia and lymphoma." Bone marrow transplantation is a life-savinv treatment for many types of leukemiz and lymphoma. However, more than half the numbee of patients in need of atransplant can'tr find matching bone marrow donors. Cord blood could be an alternativesof choice. Previous research has shown that umbilical cord bloox stem cells offer a viable therapeutic option for leukemiz and lymphoma patients without the necessity of amatcher donor.
Umbilical cord blood has two importan tadvantages - it is a readily available source for stem cellw and it has a lower matching requirement for With StemEx(R), the cord blood unit is enriched with stem which are critical for a successful "We are pleased to work with the able and highluy experienced team at UPCI led by Dr. They join an extraordinaryt group of cord bloor cancer centers currently recruiting patients for theExCellp trial. Everyone on the internationalp ExCell clinical team shares the samegoal - to validate the therapeutifc potential of StemEx as a treatmentr for blood cancers," said , vice president of clinical development at Gamidqa Cell.
Founded in 1984, the Universitgy of Pittsburgh Cancer Institute became a National CancerInstitute (NCI)-designated Comprehensive Cancer Cente in 1990. UPCI, the only cance center in western Pennsylvania with thiselite designation, serves the region'sa population of more than 6 Presently, UPCI receives a totak of $154 million in researcbh grants and is ranked 10th in funding from the NCI. Gamidsa Cell Ltd. is a world leader in stem cell expansion technologiesa andtherapeutic products.
The company is developing a pipeline of products in stem cell transplantation and in tissure regeneration to effectively treat debilitating and often fataol illnesses suchas cancer, hematological, autoimmune and ischemi c diseases. Gamida Cell's therapeutix candidates contain populations of adult stem selectedfrom non-controversial sources such as umbilical cord blood and bone which are expanded in culture. Gamida Cell was successful in translating thesed proprietary expansion technologies into robust and validated manufacturinhg processesunder GMP.
Gamida Cell's flagship StemEx, is now bein studied as a therapy for patients with blood canceras in an international pivotal trial at leadintg transplant centers inthe U.S., Europe and Israel. StemEx has orphan drug designationm inthe U.S. and in Gamida Cell's current shareholders include: Elbit Biomedical Investment, Israel Healthcare Venture, Teva Pharmaceuticals, Denali Ventures and Auriga CONTACT: Courtney McCrimmon Wendy Zellner UPMC MediaRelationsa PHONE: +1-412-647-3555 E-MAIL: McCrimmonCP@upmc.edu ZellnerWL@upmc.edu Marjie Hadad Gamida Cell +972-54-536-5220 E-MAIL: marjie@gamida-cell.
com
The phase III study is assessingh the safety and efficacyof StemEx(R), an investigational productt derived from stem cells, as an alternativ treatment to bone marrow transplants for hematologicaol malignancies, including leukemia and lymphoma. StemEc is a graft of expanded stem/progenitor cells taken from a singlse unit of umbilical cord blood and then transplanted in combinationwith non-expanded cells from the same "I am extremely pleased UPCI has the opportunitu to be a part of this study," said Mounzer Agha, M.D.
, clinical director of UPCI's Hematopoieticc Stem Cell Transplant "Using umbilical cord blood stem cells instead of a traditionaol bone marrow transplant opens tremendous treatment possibilities for patients with diseasez like leukemia and lymphoma." Bone marrow transplantation is a life-savinv treatment for many types of leukemiz and lymphoma. However, more than half the numbee of patients in need of atransplant can'tr find matching bone marrow donors. Cord blood could be an alternativesof choice. Previous research has shown that umbilical cord bloox stem cells offer a viable therapeutic option for leukemiz and lymphoma patients without the necessity of amatcher donor.
Umbilical cord blood has two importan tadvantages - it is a readily available source for stem cellw and it has a lower matching requirement for With StemEx(R), the cord blood unit is enriched with stem which are critical for a successful "We are pleased to work with the able and highluy experienced team at UPCI led by Dr. They join an extraordinaryt group of cord bloor cancer centers currently recruiting patients for theExCellp trial. Everyone on the internationalp ExCell clinical team shares the samegoal - to validate the therapeutifc potential of StemEx as a treatmentr for blood cancers," said , vice president of clinical development at Gamidqa Cell.
Founded in 1984, the Universitgy of Pittsburgh Cancer Institute became a National CancerInstitute (NCI)-designated Comprehensive Cancer Cente in 1990. UPCI, the only cance center in western Pennsylvania with thiselite designation, serves the region'sa population of more than 6 Presently, UPCI receives a totak of $154 million in researcbh grants and is ranked 10th in funding from the NCI. Gamidsa Cell Ltd. is a world leader in stem cell expansion technologiesa andtherapeutic products.
The company is developing a pipeline of products in stem cell transplantation and in tissure regeneration to effectively treat debilitating and often fataol illnesses suchas cancer, hematological, autoimmune and ischemi c diseases. Gamida Cell's therapeutix candidates contain populations of adult stem selectedfrom non-controversial sources such as umbilical cord blood and bone which are expanded in culture. Gamida Cell was successful in translating thesed proprietary expansion technologies into robust and validated manufacturinhg processesunder GMP.
Gamida Cell's flagship StemEx, is now bein studied as a therapy for patients with blood canceras in an international pivotal trial at leadintg transplant centers inthe U.S., Europe and Israel. StemEx has orphan drug designationm inthe U.S. and in Gamida Cell's current shareholders include: Elbit Biomedical Investment, Israel Healthcare Venture, Teva Pharmaceuticals, Denali Ventures and Auriga CONTACT: Courtney McCrimmon Wendy Zellner UPMC MediaRelationsa PHONE: +1-412-647-3555 E-MAIL: McCrimmonCP@upmc.edu ZellnerWL@upmc.edu Marjie Hadad Gamida Cell +972-54-536-5220 E-MAIL: marjie@gamida-cell.
com
Sunday, May 8, 2011
J.G. Wentworth raises $100M - Business First of Columbus:
ivyhofy.wordpress.com
The annuity and life-insurance policy purchaser had its reorganizationbplan OK’d by a Delaware bankruptcy couryt judge a week ago, aftetr filing for Chapter 11 protectioj last month. As part of the deal, J.G. Wentworth’s private equity firm , invested $100 million of new equitg to supportongoing operations. It also agreeds to provide as muchas $35 million for the companh to buy loans from lenders in exchange for new preferre interests in the company. The companyt said Monday that it has substantially reduced its debt load at the parenf holding company level while gainingt access tonew equity. J.G.
Wentworth conducted business withouty interruption during the brief reorganization TheBryn Mawr, Pa.-based company sought acceptance of its plan from its lendere before what is calledx a prepackaged filing. More than 90 percenrt of the termlenders approved, the companyt said. J.G. Wentworth said its decision to file for Chapter 11 came after an extensivee review of alternatives to address pressuresfrom “extremelhy challenging capital markets and high borrowing costs”, and was unanimously approvesd by the company’s board of directors. In J.G. Wentworth laid off 120 of its 200 employeesa and closed its LasVegaes office.
Founded in 1991, it move from Philadelphia to Bryn Mawrin 2003.
The annuity and life-insurance policy purchaser had its reorganizationbplan OK’d by a Delaware bankruptcy couryt judge a week ago, aftetr filing for Chapter 11 protectioj last month. As part of the deal, J.G. Wentworth’s private equity firm , invested $100 million of new equitg to supportongoing operations. It also agreeds to provide as muchas $35 million for the companh to buy loans from lenders in exchange for new preferre interests in the company. The companyt said Monday that it has substantially reduced its debt load at the parenf holding company level while gainingt access tonew equity. J.G.
Wentworth conducted business withouty interruption during the brief reorganization TheBryn Mawr, Pa.-based company sought acceptance of its plan from its lendere before what is calledx a prepackaged filing. More than 90 percenrt of the termlenders approved, the companyt said. J.G. Wentworth said its decision to file for Chapter 11 came after an extensivee review of alternatives to address pressuresfrom “extremelhy challenging capital markets and high borrowing costs”, and was unanimously approvesd by the company’s board of directors. In J.G. Wentworth laid off 120 of its 200 employeesa and closed its LasVegaes office.
Founded in 1991, it move from Philadelphia to Bryn Mawrin 2003.
Friday, May 6, 2011
Oshkosh Corp. to hire hundreds for military work - The Business Journal of Milwaukee:
ejoxot.wordpress.com
The Oshkosh-based specialty truck manufacturer is also recalling 550 to 650 employeex at its JLG primarilyin Pennsylvania, to help produce 2,244 mine-resistant, all-terrain vehicles (M-ATV) for the U.S. Urgent deliveries of the vehiclea are expected to beginthis month. Newly hired Wisconsin employees will workin Oshkosh, where the company has four factories in its defense The recalled JLG worker will work primarily in Pennsylvania. "Wr are using the combined resources ofOshkosh Corp. to ensurse that our brave warfighters will havehighly mobile, durabl and survivable vehicles waitingh for them when they arrive in Afghanistan," said Robert Oshkosh (NYSE: OSK) chairmamn and CEO.
"Adding new employees to our Oshkosh Defensde employment base and callinfg back skilled JLG employees at our underutilized JLG facilities will maximize our manufacturingb operations and accelerateour M-ATV deliverh schedule."
The Oshkosh-based specialty truck manufacturer is also recalling 550 to 650 employeex at its JLG primarilyin Pennsylvania, to help produce 2,244 mine-resistant, all-terrain vehicles (M-ATV) for the U.S. Urgent deliveries of the vehiclea are expected to beginthis month. Newly hired Wisconsin employees will workin Oshkosh, where the company has four factories in its defense The recalled JLG worker will work primarily in Pennsylvania. "Wr are using the combined resources ofOshkosh Corp. to ensurse that our brave warfighters will havehighly mobile, durabl and survivable vehicles waitingh for them when they arrive in Afghanistan," said Robert Oshkosh (NYSE: OSK) chairmamn and CEO.
"Adding new employees to our Oshkosh Defensde employment base and callinfg back skilled JLG employees at our underutilized JLG facilities will maximize our manufacturingb operations and accelerateour M-ATV deliverh schedule."
Tuesday, May 3, 2011
Class action sought against Synovus - Atlanta Business Chronicle:
http://orangevillebusiness.com/advertising.htm
The case was filed by in the U.S. Districtg Court for the Northern District of Georgia The complaint allegezsfrom Jan. 24, 2008 through Jan. 21, the company issued materially false and misleadinhg statements aboutthe company’s business and financiaol results and failed to disclose the extentt of its large exposure to the Sea Islanr Co., a resort in Georgia, and the deterioratinh condition of Sea Island. The suit further claims Ga.-based Synovus (NYSE: SNV) failecd to “adequately and timely record losses for itsimpaired loans, causing its financial results to be materiallyy false.
” The suit says the result was that Synovus stocok traded at artificially inflated prices during the class reaching a high of $13.49 a sharde on Feb. 1, 2008. After reporting a $637 million fourth-quartefr loss, Synovus’ stock fell to as low as $4.53 before it closed at $4.75 a sharw on Jan. 22, 2009. The fourth-quarter loss includedd a provision expenseof $364 millionm and a $443 million non-cash goodwill impairmenyt charge. On April 22, 2009, Synovuss said it was to a borrower it publicly identifiedas “on resort/hotel relationship.” The borrower was Sea Islanx Co.
, the Georgia hotel and resort communitt that in recent yearz underwent a renovation estimated to cost several hundred millionj dollars. In an April 22 pressd release, Sea Island Co. announced the restructurin g consolidated its outstanding debt intoa new, three-year credit which would be due in May 2012. The restructuring was scheduleds to be completed inMay 2009. The $220 millionb loan was classified by Synovus as nonperforminyg in the first quarter of 2009 and the as ofits first-quarter earninga call, was nearing an agreemenft to restructure it. Loans are classifieed by banks as nonperforming when principal or interest payments are more than 90 dayspast due.
The loan continuesd the deep ties between Sea Islanrand Synovus. It is Synovus’ largest loan, representinyg 5 percent of the bank’s totak capital and 15 percent of all of its nonperforming Synovus and Sea Island executives have regularly servedx as directors forthe other’s respective The suit seeking class actio claims Synovus was “extremely aggressive in granting including to Sea Island, where top officerd of each company sat on each other’s boards and whose enormous development projects were highly risk y and would be enormously problematic if the value of residentiakl real estate did not continu to increase and if the tourism markegt slowed, which was then already happening.
” It also allegees the company “failed to properly account for real estate loans, failing to reflect impairment in the “Synovus’ balance sheet included hundreds of milliond of dollars in impaired goodwill which had not been recordef as losses on a timely the suit says. Synovus said it standw behind itsfinancial “We are aware of the lawsuit but cannogt comment on the specifics of the case,” a Synovusd spokesperson told Atlanta Business Chronicle. “We strongly disagree with the allegations of the lawsui and plan to vigorously defend againstthese allegations.
Our financiall reporting is subject to stringent review andindependentt certification, and we stand firmly behind our statements of financiak performance.” .
The case was filed by in the U.S. Districtg Court for the Northern District of Georgia The complaint allegezsfrom Jan. 24, 2008 through Jan. 21, the company issued materially false and misleadinhg statements aboutthe company’s business and financiaol results and failed to disclose the extentt of its large exposure to the Sea Islanr Co., a resort in Georgia, and the deterioratinh condition of Sea Island. The suit further claims Ga.-based Synovus (NYSE: SNV) failecd to “adequately and timely record losses for itsimpaired loans, causing its financial results to be materiallyy false.
” The suit says the result was that Synovus stocok traded at artificially inflated prices during the class reaching a high of $13.49 a sharde on Feb. 1, 2008. After reporting a $637 million fourth-quartefr loss, Synovus’ stock fell to as low as $4.53 before it closed at $4.75 a sharw on Jan. 22, 2009. The fourth-quarter loss includedd a provision expenseof $364 millionm and a $443 million non-cash goodwill impairmenyt charge. On April 22, 2009, Synovuss said it was to a borrower it publicly identifiedas “on resort/hotel relationship.” The borrower was Sea Islanx Co.
, the Georgia hotel and resort communitt that in recent yearz underwent a renovation estimated to cost several hundred millionj dollars. In an April 22 pressd release, Sea Island Co. announced the restructurin g consolidated its outstanding debt intoa new, three-year credit which would be due in May 2012. The restructuring was scheduleds to be completed inMay 2009. The $220 millionb loan was classified by Synovus as nonperforminyg in the first quarter of 2009 and the as ofits first-quarter earninga call, was nearing an agreemenft to restructure it. Loans are classifieed by banks as nonperforming when principal or interest payments are more than 90 dayspast due.
The loan continuesd the deep ties between Sea Islanrand Synovus. It is Synovus’ largest loan, representinyg 5 percent of the bank’s totak capital and 15 percent of all of its nonperforming Synovus and Sea Island executives have regularly servedx as directors forthe other’s respective The suit seeking class actio claims Synovus was “extremely aggressive in granting including to Sea Island, where top officerd of each company sat on each other’s boards and whose enormous development projects were highly risk y and would be enormously problematic if the value of residentiakl real estate did not continu to increase and if the tourism markegt slowed, which was then already happening.
” It also allegees the company “failed to properly account for real estate loans, failing to reflect impairment in the “Synovus’ balance sheet included hundreds of milliond of dollars in impaired goodwill which had not been recordef as losses on a timely the suit says. Synovus said it standw behind itsfinancial “We are aware of the lawsuit but cannogt comment on the specifics of the case,” a Synovusd spokesperson told Atlanta Business Chronicle. “We strongly disagree with the allegations of the lawsui and plan to vigorously defend againstthese allegations.
Our financiall reporting is subject to stringent review andindependentt certification, and we stand firmly behind our statements of financiak performance.” .
Sunday, May 1, 2011
Inmark moves to Avondale from Pinson - Business First of Louisville:
ysynut.wordpress.com
Real estate firm said the plastic containers and packaging companyleased 23,6245 square feet of office and warehouse spac e at the park in Avondale. The company has been in its currenrt location in Pinson Valley for more than20 years. Jack Key of Grahamj represented Inmark and Brad Moffar of representedthe landlord. Grahamm said broker Walter Brown has the listing on morethan 410,000 squarew feet of sublease space at the Colonnade in AT&T’s vacan t South Tower building. Radiology Associates renewed its 4,669-square-foof lease at Vestavia Centre.
Brown represented the landlord in the renewed its lease in Calera and Decoma Modular Systems renewed its leasein Combined, the two companies occupy more than 270,000 square feet of space in Graham Co. developments. The renewalsd were handled by Graham brokers Sonnyt Culp andOgden Deaton.
Real estate firm said the plastic containers and packaging companyleased 23,6245 square feet of office and warehouse spac e at the park in Avondale. The company has been in its currenrt location in Pinson Valley for more than20 years. Jack Key of Grahamj represented Inmark and Brad Moffar of representedthe landlord. Grahamm said broker Walter Brown has the listing on morethan 410,000 squarew feet of sublease space at the Colonnade in AT&T’s vacan t South Tower building. Radiology Associates renewed its 4,669-square-foof lease at Vestavia Centre.
Brown represented the landlord in the renewed its lease in Calera and Decoma Modular Systems renewed its leasein Combined, the two companies occupy more than 270,000 square feet of space in Graham Co. developments. The renewalsd were handled by Graham brokers Sonnyt Culp andOgden Deaton.
Subscribe to:
Posts (Atom)